MalnutritionCHAINNCT03208725
Childhood Acute Illness and Nutrition Network
An observational study of Malnutrition and Pneumonia, run by University of Oxford at 8 sites in 5 countries.
Trial summary
The CHAIN Network aims to identify modifiable biomedical and social factors driving the greatly increased risk of mortality among young undernourished children admitted to hospital with acute illness, as inpatients and after discharge. Read more about this study
- Who is it for?
- Ages 2 to 23 months
- Conditions the study is for
- Malnutrition, Pneumonia, Diarrhea
- How many people
- 4,335 participants
- Where
- 8 sitesin 5 countries
- Study dates
- 30 Nov 2016to 31 Oct 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 23 months
- All sexes
- No healthy volunteers
- Child
Study population: Hospital and post-discharge cohort: Children being admitted to hospital. Community reference participants: Children living in the same communities as those recruited into the hospitalized cohort.
Who may be able to join
- Children 2 months-23 months.
- Admitted to hospital.
- Planning to remain within the hospital catchment area and willing to come for specified visits during the 6 month follow up period.
- Parent or guardian consents on child's behalf.
- Aged 2 to 23 months
- Living in the same community as the acutely ill children recruited.
Show all 11Show fewer
- Not having an acute illness requiring hospital admission
- Absence of known, but untreated HIV or TB
- Not admitted to hospital within the last 14 days
- Not previously included in the study
- Parent or guardian consents on child's behalf.
Who cannot join
- Requiring immediate resuscitation at admission to hospital*
- Unable to tolerate oral feeds while in his/her usual state of health
- Underlying terminal illness that in the opinion of the treating physician is likely to lead to death within 6 months (e.g., cancer, congenital heart disease)
- Diagnosed with a condition that in the opinion of the treating physician is likely to require surgery within 6 months
- Diagnosed chromosomal abnormality (syndromically or genetically diagnosed abnormality)
- Primary reason for admission is poisoning, trauma or a surgical condition
Show all 9Show fewer
- Previously enrolled in this study
- Sibling currently or previously enrolled in this study
- ( children requiring resuscitation will be defined as those with on-going cardiac or pulmonary arrest or judged to be peri-arrest by the attending physician)
Trial locations and contacts
8 sites in 5 countries.
8 sites in 5 countries
Kenya3 sites
Kilifi County Hospital
Kilifi
Migori County Hospital
Migori
Mbagathi District Hospital
Nairobi
Bangladesh2 sites
Matlab Hospital
Dhaka, Chittagong
ICDDR,B Dhaka Hospital
Dhaka
About this study
Official title: Building the Evidence Base for Appropriate Care of the Sick, Undernourished Child in Limited Resource Settings
The CHAIN Network aims to identify modifiable biomedical and social factors driving the greatly increased risk of mortality among young undernourished children admitted to hospital with acute illness, as inpatients and after discharge. The study will inform priorities, risks and targeting for multi-faceted interventional trials.
CHAIN is a multi-centre cohort study with a nested case control analysis of stored biological samples. Study sites are located in Africa and South Asia. Children will be recruited at admission to hospital, stratified by nutritional status. Exposures will be assessed at admission, during hospitalisation, at discharge, and at two time points after discharge. The main outcomes of interest are mortality, re-admission to hospital and failure of nutritional recovery up to 180 days after discharge. To determine community health norms, an additional sample of children living in the same communities will be enrolled and assessed at one time point only.
Read the detailed description
Despite an overall reduction of child mortality in LMICs, acutely-ill undernourished children continue to have a greatly elevated risk of death, both during hospitalisation and following discharge. However, we currently lack robust evidence for their management. Factors underlying the risks of mortality may relate to the acute illness itself, to children's longer term health trajectories, or to the home nutritional and care environment. The ultimate goal of the CHAIN Network is to identify and prioritize actionable intervention targets to reduce mortality among acutely ill undernourished children.
CHAIN's initial aim is to better understand the characteristics that determine increased risk of mortality in this vulnerable population, whether biological (related to infection, immunity and metabolism), nutritional (intake and anthropometry), health system factors (affecting management and discharge) or behavioural (community/caregiver interactions). CHAIN brings clinicians and scientists together from a variety of high-burden settings in Africa and South Asia. CHAIN will establish prospective cohorts of acutely ill young children across different geographies with differing population, social and environmental characteristics (stunted vs. wasting, rural vs. urban and presence of risk factors such as malaria and HIV).
Eight sites will be involved, including three hospitals in Kenya (Kilifi County, Migori County and Mbagathi District), two in Bangladesh (Matlab and the icddr,b Dhaka), and one in each of Uganda (Mulago), Malawi (Queen Elizabeth Community Hospital), Pakistan (Civil Hospital Karachi) and in West Africa (TBA). Site will enroll children at admission to hospital, and assess their clinical, social and economic status at admission, during hospitalisation, at discharge and during follow up for 180 days after discharge. The sites will also enrol children from the community to determine community norms (where ill and undernourished children would be expected to typically recover to). Protocols and procedures will be carefully harmonised across sites.
Children aged 2 months to 2 years admitted to hospital will be considered for inclusion and enrolment stratified by nutritional status. Following informed consent, baseline data of prognostic importance, including demographic and social information, a detailed clinical examination, anthropometry and measurement of vital signs, including pulse oximetry, will be collected using a standard proforma. A research blood sample will be collected together with the routine clinical blood draw to minimize the patient's discomfort. Rectal swabs and faecal sample will also be obtained from all children.
During admission, care will be provided according to WHO and national guidelines. Children will be reviewed daily and clinical features, progress and treatment received recorded on a structured case report form. In the event of death in hospital, a standard audit questionnaire will be completed. During admission, primary caregivers, usually the mother, will be interviewed screened for mental health problems. At discharge, anthropometry, a clinical assessment and blood, rectal swab and whole stool collected. Families will be linked with chronic care services where needed.
A home visit will be conducted for all participants, the GPS location recorded. Information homestead infrastructure, water and sanitation, population, livelihood, child care and socioeconomic characteristics. Children will be followed up at 45, 90 and 180 days after discharge. A health questionnaire will document health and social events, and dietary intake. Anthropometry, and faecal and blood samples collected.
Caregivers will be asked to attend the study hospital should the caregiver believes they may require hospitalisation. Study participants who are re-admitted to hospital will undergo standardised clinical assessment including history, examination and sample collection. In the event of death occurring outside the study hospital, a standard verbal autopsy (VA) will be completed by trained staff within 28 days of becoming aware of a death. VAs along with all available information will be used to ascribe causes of death.
Community participants will be invited to the study clinic for assessment. Following informed consent, they will have a clinical examination, anthropometry, blood and stool samples as children who are admitted. Children requiring non-urgent medical care will be eligible for inclusion as community participants but will be given basic treatment in the study clinic and/or referred to appropriate treatment centres. Study staff will refer community participants with incomplete vaccination or requiring care for chronic conditions as needed.
Several domains of exposure will be assessed: demographic, nutrition and metabolism; acute and chronic conditions; community-acquired and nosocomial infections (including antimicrobial resistance); gut function \& dysbiosis; inflammation; responses to treatment; and the home care environment.
Successful design of an intervention package to address post-discharge child mortality will require attention social and economic agency and vulnerability, access and interactions with health services, and ethical considerations. A qualitative sub-study will examine these factors in context in rural and urban sites in Kenya and Bangladesh to identify critical social limitations and potential approaches to intervention. These data will inform the network's development, piloting, and implementation of interventions.
Additional sub-studies at a subset of sites will also examine in more detail the diagnosis and role of TB; and changes in functional immune responses; body composition and neurodevelopment during follow up.
- Conditions
- Malnutrition, Pneumonia, Diarrhea, Sepsis, Bacteremia, HIV/AIDS
- Keywords
- Malnutrition, Hospitalization, Acute Illness, Pediatric, Post-discharge mortality, Mortality, Cohort, Nested case control, Antimicrobial resistance, Antibiotic, Feeding, Undernutrition
- Medical subject headings
- Malnutrition, Pneumonia, Diarrhea, Sepsis, Bacteremia, Acquired Immunodeficiency Syndrome, Intestinal Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Hospitalized children with severe wasting or kwashiorkor (SWK) | Children recruited at admission to hospital and followed up for 180 days post-discharge. | |
| Community reference participants (CP) | Children recruited from the community who are seen a single appointment in the community. | |
| Hospitalized children with moderate wasting (MW) | Children recruited at admission to hospital and followed up for 180 days post-discharge. | |
| Hospitalized children without wasting (NW) | Children recruited at admission to hospital and followed up for 180 days post-discharge. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mortality
Assessed using clinical and civil records and verbal autopsy
Measured: Up to 30 days after admission to hospital
Mortality
Assessed using clinical and civil records and verbal autopsy
Measured: Up to 180 days after discharge from hospital
Secondary outcomes (4)
Rehospitalization
Number of participants, assessed from direct observation or clinical records
Measured: Up to 180 days after discharge from hospital
Change in weight-for-height z-score
Post-discharge growth
Measured: Up to 180 days after discharge from hospital
Change in length-for-age z-score
Post-discharge growth
Measured: Up to 180 days after discharge from hospital
Change in mid-upper arm circumference
Post-discharge growth
Measured: Up to 180 days after discharge from hospital
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jul 2017
- Study start30 Nov 2016
- Primary completion31 Jan 2020
- Study completion31 Oct 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for MalnutritionStudies of the same condition, open and under way.
- More trials run by University of OxfordThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 4,335 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Oxford
- Sponsor type
- University, hospital or other
- Collaborators
- University of Washington, Kenya Medical Research Institute, KEMRI-Wellcome Trust Collaborative Research Program, Makerere University, Oregon Health and Science University, The Hospital for Sick Children, University of Amsterdam, University of Malawi, Aga Khan University, International Centre for Diarrhoeal Disease Research, Bangladesh
- Responsible party
- Sponsor
- Investigators
- James A Berkley, MBBS, FRCPCH, Principal investigator, University of OxfordJudd L Wilson, MD, MPH, Principal investigator, University of Washington
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03208725
- Sponsor's protocol ID
- OPP1131320
- Acronym
- CHAIN
- Status last verified
- May 2020
- First submitted
- 8 Mar 2017
- Last updated
- 20 May 2020
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Njunge JM, Tickell K, Diallo AH, Sayeem Bin Shahid ASM, Gazi MA, Saleem A, Kazi Z, Ali S, Tigoi C, Mupere E, Lancioni CL, Yoshioka E, Chisti MJ, Mburu M, Ngari M, Ngao N, Gichuki B, Omer E, Gumbi W, Singa B, Bandsma R, Ahmed T, Voskuijl W, Williams TN, Macharia A, Makale J, Mitchel A, Williams J, Gogain J, Janjic N, Mandal R, Wishart DS, Wu H, Xia L, Routledge M, Gong YY, Espinosa C, Aghaeepour N, Liu J, Houpt E, Lawley TD, Browne H, Shao Y, Rwigi D, Kariuki K, Kaburu T, Uhlig HH, Gartner L, Jones K, Koulman A, Walson J, Berkley J. The Childhood Acute Illness and Nutrition (CHAIN) network nested case-cohort study protocol: a multi-omics approach to understanding mortality among children in sub-Saharan Africa and South Asia. Gates Open Res. 2022 Nov 3;6:77. doi: 10.12688/gatesopenres.13635.2. eCollection 2022.
PubMed 36415883Tickell KD, Denno DM, Saleem A, Ali A, Kazi Z, Singa BO, Otieno C, Mutinda C, Ochuodho V, Richardson BA, Asbjornsdottir KH, Hawes SE, Berkley JA, Walson JL. Enteric Permeability, Systemic Inflammation, and Post-Discharge Growth Among a Cohort of Hospitalized Children in Kenya and Pakistan. J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):768-774. doi: 10.1097/MPG.0000000000003619. Epub 2022 Sep 20.
PubMed 36123771Childhood Acute Illness and Nutrition Network. Childhood Acute Illness and Nutrition (CHAIN) Network: a protocol for a multi-site prospective cohort study to identify modifiable risk factors for mortality among acutely ill children in Africa and Asia. BMJ Open. 2019 May 5;9(5):e028454. doi: 10.1136/bmjopen-2018-028454.
PubMed 31061058
Study at a glance
From the registry record, last updated by the sponsor on 20 May 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Building the Evidence Base for Appropriate Care of the Sick, Undernourished Child in Limited Resource Settings
- ClinicalTrials.gov ID
- NCT03208725
- Acronym / sponsor ID
- CHAIN / OPP1131320
- Conditions
- Malnutrition, Pneumonia, Diarrhea, Sepsis, Bacteremia, HIV/AIDS
- Keywords
- Malnutrition, Hospitalization, Acute Illness, Pediatric, Post-discharge mortality, Mortality, Cohort, Nested case control
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 4,335 participants (actual)
- Lead sponsor
- University of OxfordUniversity, hospital or other
- Collaborators
- University of Washington, Kenya Medical Research Institute, KEMRI-Wellcome Trust Collaborative Research Program, Makerere University, Oregon Health and Science University, The Hospital for Sick Children, University of Amsterdam, University of Malawi, Aga Khan University, International Centre for Diarrhoeal Disease Research, Bangladesh
- Study start
- 30 Nov 2016 (actual)
- Primary completion
- 31 Jan 2020 (actual)
- Study completion
- 31 Oct 2020 (estimated)
- First posted
- 5 Jul 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The CHAIN Network aims to identify modifiable biomedical and social factors driving the greatly increased risk of mortality among young undernourished children admitted to hospital with acute illness, as inpatients and after discharge. The study will inform priorities, risks and targeting for multi-faceted interventional trials.
CHAIN is a multi-centre cohort study with a nested case control analysis of stored biological samples. Study sites are located in Africa and South Asia. Children will be recruited at admission to hospital, stratified by nutritional status. Exposures will be assessed at admission, during hospitalisation, at discharge, and at two time points after discharge. The main outcomes of interest are mortality, re-admission to hospital and failure of nutritional recovery up to 180 days after discharge. To determine community health norms, an additional sample of children living in the same communities will be enrolled and assessed at one time point only.
Detailed description
Despite an overall reduction of child mortality in LMICs, acutely-ill undernourished children continue to have a greatly elevated risk of death, both during hospitalisation and following discharge. However, we currently lack robust evidence for their management. Factors underlying the risks of mortality may relate to the acute illness itself, to children's longer term health trajectories, or to the home nutritional and care environment. The ultimate goal of the CHAIN Network is to identify and prioritize actionable intervention targets to reduce mortality among acutely ill undernourished children.
CHAIN's initial aim is to better understand the characteristics that determine increased risk of mortality in this vulnerable population, whether biological (related to infection, immunity and metabolism), nutritional (intake and anthropometry), health system factors (affecting management and discharge) or behavioural (community/caregiver interactions). CHAIN brings clinicians and scientists together from a variety of high-burden settings in Africa and South Asia. CHAIN will establish prospective cohorts of acutely ill young children across different geographies with differing population, social and environmental characteristics (stunted vs. wasting, rural vs. urban and presence of risk factors such as malaria and HIV).
Eight sites will be involved, including three hospitals in Kenya (Kilifi County, Migori County and Mbagathi District), two in Bangladesh (Matlab and the icddr,b Dhaka), and one in each of Uganda (Mulago), Malawi (Queen Elizabeth Community Hospital), Pakistan (Civil Hospital Karachi) and in West Africa (TBA). Site will enroll children at admission to hospital, and assess their clinical, social and economic status at admission, during hospitalisation, at discharge and during follow up for 180 days after discharge. The sites will also enrol children from the community to determine community norms (where ill and undernourished children would be expected to typically recover to). Protocols and procedures will be carefully harmonised across sites.
Children aged 2 months to 2 years admitted to hospital will be considered for inclusion and enrolment stratified by nutritional status. Following informed consent, baseline data of prognostic importance, including demographic and social information, a detailed clinical examination, anthropometry and measurement of vital signs, including pulse oximetry, will be collected using a standard proforma. A research blood sample will be collected together with the routine clinical blood draw to minimize the patient's discomfort. Rectal swabs and faecal sample will also be obtained from all children.
During admission, care will be provided according to WHO and national guidelines. Children will be reviewed daily and clinical features, progress and treatment received recorded on a structured case report form. In the event of death in hospital, a standard audit questionnaire will be completed. During admission, primary caregivers, usually the mother, will be interviewed screened for mental health problems. At discharge, anthropometry, a clinical assessment and blood, rectal swab and whole stool collected. Families will be linked with chronic care services where needed.
A home visit will be conducted for all participants, the GPS location recorded. Information homestead infrastructure, water and sanitation, population, livelihood, child care and socioeconomic characteristics. Children will be followed up at 45, 90 and 180 days after discharge. A health questionnaire will document health and social events, and dietary intake. Anthropometry, and faecal and blood samples collected.
Caregivers will be asked to attend the study hospital should the caregiver believes they may require hospitalisation. Study participants who are re-admitted to hospital will undergo standardised clinical assessment including history, examination and sample collection. In the event of death occurring outside the study hospital, a standard verbal autopsy (VA) will be completed by trained staff within 28 days of becoming aware of a death. VAs along with all available information will be used to ascribe causes of death.
Community participants will be invited to the study clinic for assessment. Following informed consent, they will have a clinical examination, anthropometry, blood and stool samples as children who are admitted. Children requiring non-urgent medical care will be eligible for inclusion as community participants but will be given basic treatment in the study clinic and/or referred to appropriate treatment centres. Study staff will refer community participants with incomplete vaccination or requiring care for chronic conditions as needed.
Several domains of exposure will be assessed: demographic, nutrition and metabolism; acute and chronic conditions; community-acquired and nosocomial infections (including antimicrobial resistance); gut function \& dysbiosis; inflammation; responses to treatment; and the home care environment.
Successful design of an intervention package to address post-discharge child mortality will require attention social and economic agency and vulnerability, access and interactions with health services, and ethical considerations. A qualitative sub-study will examine these factors in context in rural and urban sites in Kenya and Bangladesh to identify critical social limitations and potential approaches to intervention. These data will inform the network's development, piloting, and implementation of interventions.
Additional sub-studies at a subset of sites will also examine in more detail the diagnosis and role of TB; and changes in functional immune responses; body composition and neurodevelopment during follow up.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Hospitalized children with severe wasting or kwashiorkor (SWK) | – | –Children recruited at admission to hospital and followed up for 180 days post-discharge. |
| Community reference participants (CP) | – | –Children recruited from the community who are seen a single appointment in the community. |
| Hospitalized children with moderate wasting (MW) | – | –Children recruited at admission to hospital and followed up for 180 days post-discharge. |
| Hospitalized children without wasting (NW) | – | –Children recruited at admission to hospital and followed up for 180 days post-discharge. |
Who may qualify
- Ages
- 2 to 23 months
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- Hospital and post-discharge cohort: Children being admitted to hospital. Community reference participants: Children living in the same communities as those recruited into the hospitalized cohort.
Key inclusion criteria (11 listed)
- Children 2 months-23 months.
- Admitted to hospital.
- Planning to remain within the hospital catchment area and willing to come for specified visits during the 6 month follow up period.
- Parent or guardian consents on child's behalf.
- Aged 2 to 23 months
Key exclusion criteria (9 listed)
- Requiring immediate resuscitation at admission to hospital*
- Unable to tolerate oral feeds while in his/her usual state of health
- Underlying terminal illness that in the opinion of the treating physician is likely to lead to death within 6 months (e.g., cancer, congenital heart disease)
- Diagnosed with a condition that in the opinion of the treating physician is likely to require surgery within 6 months
- Diagnosed chromosomal abnormality (syndromically or genetically diagnosed abnormality)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Mortality
Time frame: Up to 30 days after admission to hospital
Assessed using clinical and civil records and verbal autopsy
Mortality
Time frame: Up to 180 days after discharge from hospital
Assessed using clinical and civil records and verbal autopsy
4 secondary outcomes
Rehospitalization
Time frame: Up to 180 days after discharge from hospital
Change in weight-for-height z-score
Time frame: Up to 180 days after discharge from hospital
Change in length-for-age z-score
Time frame: Up to 180 days after discharge from hospital
Change in mid-upper arm circumference
Time frame: Up to 180 days after discharge from hospital
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 May 2020.
- Derived from this study: PubMed 36415883Njunge JM, Tickell K, Diallo AH, Sayeem Bin Shahid ASM, Gazi MA, Saleem A, Kazi Z, Ali S, Tigoi C, Mupere E, Lancioni CL, Yoshioka E, Chisti MJ, Mburu M, Ngari M, Ngao N, Gichuki B, Omer E, Gumbi W, Singa B, Bandsma R, Ahmed T, Voskuijl W, Williams TN, Macharia A, Makale J, Mitchel A, Williams J, Gogain J, Janjic N, Mandal R, Wishart DS, Wu H, Xia L, Routledge M, Gong YY, Espinosa C, Aghaeepour N, Liu J, Houpt E, Lawley TD, Browne H, Shao Y, Rwigi D, Kariuki K, Kaburu T, Uhlig HH, Gartner L, Jones K, Koulman A, Walson J, Berkley J. The Childhood Acute Illness and Nutrition (CHAIN) network nested case-cohort study protocol: a multi-omics approach to understanding mortality among children in sub-Saharan Africa and South Asia. Gates Open Res. 2022 Nov 3;6:77. doi: 10.12688/gatesopenres.13635.2. eCollection 2022.
- Derived from this study: PubMed 36123771Tickell KD, Denno DM, Saleem A, Ali A, Kazi Z, Singa BO, Otieno C, Mutinda C, Ochuodho V, Richardson BA, Asbjornsdottir KH, Hawes SE, Berkley JA, Walson JL. Enteric Permeability, Systemic Inflammation, and Post-Discharge Growth Among a Cohort of Hospitalized Children in Kenya and Pakistan. J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):768-774. doi: 10.1097/MPG.0000000000003619. Epub 2022 Sep 20.
- Derived from this study: PubMed 31061058Childhood Acute Illness and Nutrition Network. Childhood Acute Illness and Nutrition (CHAIN) Network: a protocol for a multi-site prospective cohort study to identify modifiable risk factors for mortality among acutely ill children in Africa and Asia. BMJ Open. 2019 May 5;9(5):e028454. doi: 10.1136/bmjopen-2018-028454.
- The CHAIN NetworkLink provided by the sponsor.
- Childhood Acute Illness and Nutrition (CHAIN) Network: a protocol for a multi-site prospective cohort study to identify modifiable risk factors for mortality among acutely ill children in Africa and AsiaLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Malnutrition
Not yet recruitingObservational study
Malnutrition and Sarcopenia in Adults With Chronic Kidney Disease in Tunisia
Malnutrition, Sarcopenia
Not yet recruiting
Tolerance and Acceptability of an Oral Nutrition Supplement
Disease Related Malnutrition
RecruitingObservational study
Clinical and Laboratory Study of Methylmalonic Acidemia
Organic Acidemia, Methylmalonic Acidemia
RecruitingObservational study
Hospital-Based Prospective Cohort of Malnutrition Under 6-Month Study (HOSPIC-6-Study)
Malnutrition, Infant, Malnutrition
Recruiting
Identification of Anti-HIF 1alpha Autoantibodies in Patients With Anorexia Nervosa and Characterization of Their Pathogenic Potential in Undernutrition-associated Hepatic Cytolysis
Hepatic Cytolysis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
James A Berkley, MBBS, FRCPCH principal investigator
University of Oxford
Judd L Wilson, MD, MPH principal investigator
University of Washington
8 sites in 5 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Malnutrition and Pneumonia, run by University of Oxford at 8 sites in 5 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 11 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 20 May 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 8 sites in Kenya, Bangladesh, Malawi, Pakistan, Uganda. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mortality (time frame: Up to 30 days after admission to hospital). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03208725, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2020.